[1]
Hameed , I. et al. 2023. MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy. Journal of the Pakistan Medical Association. 73, 2 (Feb. 2023), 446–447. DOI:https://doi.org/10.47391/JPMA.7258.